Hypertension is a common health problem concerning wide number of populations and a leading global risk factor for the burden of cardiovascular (CV) disease. 1 Hypertensive patients often have abnormalities in systolic function and left ventricular (LV) diastolic filling. 2 LV diastolic dysfunction (LVDD), also referred to as heart failure (HF) with a preserved LV ejection fraction (HFpEF), is associated with significant morbidity and mortality 3 and it is predicted to become the most common type of HF. 4 When compared to patients with HF with a reduced ejection fraction (HFrEF), patients with HFpEF are older, more often female, more often have hypertension, renal dysfunction, atrial fibrillation, and pulmonary disease. 5, 6 Diagnosis and follow-up for high blood pressure (BP) relies mostly on office (clinical) BP values although several artifacts can affect office BP measurements (BPM). Ambulatory BPM (ABPM) is a method in which repeated BP readings take place while the patient undergoes normal daily activities. A 24-hour BP profile is detected for diagnosing hypertension. ABPM has proven to be a more accurate method than in-office BPM in CV risk determination 7 and in controlling BP in treated hypertensive patients. 8,9 ABPM also correlates more closely to several measures of hypertensive end-organ damage 10 and is superior in predicting CV morbidity and mortality when compared to in-office BPM. 7, 11 There is evidence that average 24-hour ABPM is related to LV dysfunction 12,13 and also that ambulatory pulse pressure (APP) 14,15 and in-office PP 16 show positive correlation with LVDD. The nondipping status seems to correlate with LVDD in hypertensives 17, 18 and also in normotensives, 19 but there is at least 1 study where the prevalence of LVDD did not differ among dipper and nondipper hypertensives. 20 In this prospective cohort study, our goal was to determine the association between ABPM and the development of LVDD in middle-aged subjects with over 20 years of followup time. The study population consists of 414 middle-aged (mean age 49.4) (during enrolment) subjects of the Oulu Project Elucidating Risk of Atherosclerosis (OPERA). To our knowledge, this is the first study to evaluate the predictive 
value of ABPM and the development of LVDD with such a long follow-up period.
METHODS

Subjects
The study population is from the OPERA project, which is a population-based, epidemiological study designed to address the risk factors and disease end-points of atherosclerotic CV diseases. The study population at baseline consists of a hypertensive cohort (300 men and 300 women) and a control cohort (300 men and 300 women) living in the city of Oulu and were 40-59 years old at the time of recruitment. 21 The hypertensive cohort consist of randomly selected, age-matched (15 men and 15 women per year) patients from the Social Insurance Institute register for reimbursement of antihypertensive medication. They were entitled to a special refund (higher reimbursement class) of antihypertensive medication. For each hypertensive subject, an age-and sex-matched control was randomly selected from the national health register excluding subjects with the right to reimbursement for hypertension medication. They were recruited by an invitation letter during December 1990 to March 1993. Both the hypertensive and the control men were recruited during December 1990 to May 1992 and the women approximately a year later. A total of 520 men (86.7%) and 525 women (87.5%) participated: 259 control men (86.3%), 261 hypertensive men (87%), 267 control women (89%), and 258 hypertensive women (86%), the overall participation rate being 87.1%. The participating study subjects attended the research laboratory of the Department of Internal Medicine, University of Oulu.
After 20 years, the subjects were recruited for revisit. During the recruitment, 232 participants were deceased. Of the 813 survivors, 600 were available for re-examinations. The subjects who had ABPM at baseline and reliable echocardiographic measurements at follow-up were included in the present study. Excluding criteria included mitral regurgitation and/or LV ejection fraction <50%. Only 5 subjects were excluded because of LV ejection fraction ≤50%. A total of 414 subjects were included in this study. The mortality data were collected up to 2014 from the National Death Registry and by then 241 subjects were deceased; 7.8% of the subjects died of a CV disease event and 14,8% died of other causes. This study was approved by the Ethical Committee of the University of Oulu, and all the subjects volunteered to participate.
Clinical measurements
Extensive examinations were performed during enrolment 1990-1993 and at the end of the follow-up period in 2013-2014. At baseline weight, height, waist, and hip were measured and BPM were carried out at the visit. Body mass index was calculated as weight (kg) divided by height squared (m 2 ), and body surface area was determined by the Dubois equation. 22 Systolic BP (SBP) and diastolic BP (DBP) are the averages of the second and third measurements. PP was calculated reducing DBP from SBP.
At baseline, ABPM was recorded with a noninvasive fully automatic SpaceLabs90207 oscillometric unit (SpaceLabs, Redmond, WA). It was set to take a measurement every 15 minutes between 04:00 am to 12:00 pm and every 20 minutes between 12:00 PM to 04:00 AM. The British Hypertension Society and the US Association for the Advancement of Medical Instrumentation have previously settled the accuracy and reproducibility of the BP readings acquired with this device. The proper positioning of the cuff was ensured by means of the similarity (difference <5 mm Hg) between 4 SpaceLabs BPMs and 4 auscultatory readings using a Y-connector, and the patients were instructed to relax their arm during the measurement. Values of SBP less than 70 or more than 250 mm Hg, DBP less than 40 or more than 150 mm Hg, and heart rate less than 40 or more than 150 beats/min were automatically excluded from the analysis. Less than 3% of the BP readings were rejected as artifacts on the basis of these criteria. 23 During the follow-up period, the ABPM was recorded with Oscar 2 oscillometric ambulatory blood pressure monitor (SunTech Medical). 24 AccuWin Pro V3 software was used in the analysis of ABPM data.
All the laboratory analyses were acquired after an overnight fast. Venous blood was drawn into EDTA sample tubes. Plasma was separated by centrifugation at 2,000-2,600 rounds per minute for 10 minutes and held at 4 °C until further analyses, which were done, if possible, within 2 days after the blood samples had been drawn. Otherwise, plasma was stored at −20 °C to −70 °C for coming analyses. The routine clinical laboratory tests were carried out in the Central Laboratory of the Oulu University Hospital. Concentrations of N-terminal pro-atrial natriuretic peptide were measured as described previously 25 
Echocardiographic measurements
The baseline echocardiographic measurements were performed by the same experienced cardiologist blinded to the patients' clinical data with a Hewlett-Packard ultrasound color system Sonos 500 (Hewlett-Packard Company, MA). M-Mode, 2-dimensional, and Doppler examinations were performed. 26 The left ventricular mass (LVM) was calculated using the formula of Devereux et al. 27 and the LVM index ( by dividing the difference between LVM values by body surface area. At follow-up visit, the study subjects underwent an echocardiographic examination in a core laboratory using a GE Healthcare Vivid E 9 version 110. x.x ultrasound system (General Electric Company, Fairfield, CT). Standard and modern parameters including tissue Doppler-based measurements were determined according to the American Society of Echocardiography recommendations. 28 E wave in the pulsed Doppler registration depicts the early mitral inflow in diastole, and E' in the tissue Doppler registration measures the mitral annular longitudinal motion during early diastole. 29 The ratio of E to E' (E/E') is considered to be one of the best echocardiographic measurements of diastolic dysfunction. 30 
Statistical methods
The 1-way analysis of variance was used to assess whether continuous variables differed statistically significantly between the subjects divided in 3 subgroups based on E/ E' . A χ 2 -test was carried out to assess the frequency differences. The power of different factors to predict E/E' was assessed in the general linear multivariate model after adjusting with other relevant univariate predictors. An E/E' value ≧15 was used as a criterion for LVDD. To determine correlations between the change in 24-hour mean ABPM and the change in echocardiographically measured parameters Pearson's coefficient of correlation was used. All calculations were made with the SPSS (version 21; SPSS) statistical package. A P value <0.05 was considered to be statistically significant.
RESULTS
The study population was divided into 3 subgroups according to follow-up E/E' . The first subgroup (E/E' ≤ 8) consisted of 78, the second subgroup (8 < E/E' < 15) of 303, and the third subgroup (E/E' ≥ 15) of 33 subjects. E/E' ≥15 indicates significant LVDD. The values are mean ± SD or percentage of patients. E wave in the pulsed Doppler registration describes the ejection phase of mitral flow in early diastole and E' in the tissue Doppler registration measures the mitral annulus movement in early diastole, the ratio of E to E' is one of the best echocardiographic measurements of diastolic dysfunction; E integral = the area of the E wave, A wave describes the atrial booster in mitral flow in late diastole measured by pulsed Doppler, A integral = the area of the A wave, the ratio of E integral and A integral describes diastolic function. Significant P values are bolded. Abbreviations: ACE, angiotensin-converting enzyme, BP, blood pressure, eGFR, estimated glomerular filtration rate; FS, fractional shortening; hs-CRP, high-sensitivity C-reactive protein; LAD, left atrial diameter; LDL-cholesterol, lowdensity-lipoprotein-cholesterol; LVIDD, left ventricular internal diameter in diastole; LVMI, left ventricular mass index, NT-proANP, N-terminal pro-atrial natriuretic peptide.
Association of baseline characteristics and E/E' subgroups at follow-up
Several baseline clinical variables differed significantly among the E/E' subgroups after over 20 years of followup (Table 1 ). Baseline factors of higher age (P = 0.005), female gender (P = 0.003), the proportion of diabetics (P = 0.001), shorter height (P < 0.001), larger body mass index (P = 0.028), higher in-office SBP (P = 0.001), higher in-office PP (P < 0.001), higher level of NT-proANP (P < 0.001), fasting plasma glucose (P = 0.001), and the use of antihypertensive therapy (P = 0.017) were associated with the development of LVDD. In contrast to those mentioned previously, waist circumference, waist/hip ratio, DBP, heart rate, estimated glomerular filtration rate, low-density-lipoprotein-cholesterol, high-sensitivity C-reactive protein, LV internal diameter in diastole, fractional shortening, LVM index, left atrial diameter, or E/A integral were not significantly different between the E/E' subgroups in the univariate analysis. These general characteristics of the study population are shown in the Table 1 .
Baseline ABPMs according to E/E' at follow-up
None of the continuous systolic or diastolic ABPM (24-hour mean, daytime mean, or nighttime mean) predicted the development of LVDD. Twenty-four-hour mean, daytime mean, and nighttime mean PP (P < 0.001) showed significant association with E/E' in the univariate analysis. The data are shown in Table 2 before and after adjustments. The PP measurements (PPM) were tested on at a time in the multivariate general linear model using the statistically significant baseline clinical variables (age, sex, diabetic status, height, in-office SBP, in-office PP, NT-proANP, and the use of antihypertensive therapy) as confounding factors. Twenty-fourhour mean PP was also adjusted with 24-hour mean DBP, daytime mean PP with daytime mean DBP and nighttime mean PP with nighttime mean DBP. All of the PPM (24-hour mean (P = 0.001), daytime mean (P = 0.016), nighttime mean (P = 0.015)) predicted the development of LVDD after over 20 years of follow-up even after relevant adjustments. We also tested the results including the 5 excluded subjects with LV ejection fraction ≤50%, but this had no effect in the predictive value of PPM in the development of LVDD.
Association of circadian BP profiles and E/E' at follow-up
We also considered different circadian BP profiles and their relation to E/E' . Depending on the size of nighttime BP fall (NF), patients were categorized into 4 groups: dippers (NF by 10-20%), nondippers (NF by 0-10%), extreme dippers (NF by >20%), and risers (no NF). These 4 groups were considered separately in SBP, DBP, and PP parameters. None of the circadian BP profiles predicted the development of LVDD in our study (data not shown).
The change in ABPMs according to E/E' at follow-up
ABPM was also recorded at follow-up from a total of 381 subjects. Seventy-three of the subjects were in subgroup 1, 280 in subgroup 2, and 28 in subgroup 3. The whole study group (N = 381) was observed to experience an increase in all of the SBP and PP measurements and a decrease in all of the DBP measurements ( Table 3 ). The purpose of this analysis was to determine the change in ABPM during the 20 years of follow-up. A substantial increase in PPM was observed The values are mean ± SD. E/E' was divided to 3 subgroups (subgroup 1: E/E' ≤ 8, subgroup 2: 8 < E/E' < 15, subgroup 3: E/E' ≥ 15 indicating significant diastolic dysfunction). Abbreviations: ANCOVA, analysis of covariance; DBP, diastolic blood pressure; PP, pulse pressure; SBP, systolic blood pressure.
a Unadjusted. b ANCOVA analysis with adjustments for age, sex, height, body mass index, diabetic status, in-office systolic blood pressure, in-office pulse pressure, N-terminal pro-atrial natriuretic peptide, and the use of antihypertensive therapy.
c Also adjusted with 24-hour mean DBP. d Also adjusted with daytime mean DBP. e Also adjusted with nighttime mean DBP.
in every subgroup during the 20-year follow-up period (P from<0.001 to 0.001). The increase in 24-hour mean, daytime mean, and nighttime mean PP was discovered to be the highest among those who developed LVDD (E/E' ≥ 15) compared to those whose E/E' <15 (P from <0.001 to 0.001).
The results are presented in Table 3 .
ABPM changes and the correlation with echocardiographically measured parameter changes
We also evaluated the correlation coefficients between the change in 24-hour mean ABPM and the change in echocardiographically measured parameters (Table 4 ). The change The values are mean ± SD. E/E' was divided to three subgroups (subgroup 1: E/E' ≤ 8, subgroup 2: 8 < E/E' < 15, subgroup 3: E/E' ≥ 15 indicating significant diastolic dysfunction). Abbreviations: DBP, diastolic blood pressure; PP, pulse pressure; SBP, systolic blood pressure.
in 24-hour mean DBP correlated with the change in E/A integral (r = −0.220, P ≤ 0.001), and the change in 24-hour mean PP correlated with the change in left ventricular diameter in diastole (r = 0.113, P = 0.034).
DISCUSSION
Since the outcome of several trials addressing the management of HFpEF to date has been poor, 31 it is important to further understand the mechanisms and risk factors underlying this problem. The present follow-up study showed that APP measurement (APPM) had an association with the development of LVDD over 20 years of follow-up among middle-aged subjects. To our knowledge, this is the first study to suggest the predictive value of APPM in the development of LVDD with a follow-up period of over 20 years, even though the group with severe diastolic dysfunction is quite small. These findings suggest that APPM has an independent predictive value in the development of LVDD. Perkiömäki et al., 2016 , suggested that a high in-office PP is an independent predictor of the development of LVDD during 20 years of follow-up. 32 This study, as ours was a part of the OPERA cohort consisting of the same study population. The prognostic value of in-office PP and APP can be different, mainly because the statistic strength of the BPM (more numerous during ABPM) could provide a more significant linkage with future CV events. 4 Therefore, we wanted to address APP and its predictive value in the development of LVDD. In some prior cross-sectional studies, the association between APP and LVDD has been discovered. Rizzo et al., 2004 , suggested that APP >60 mm Hg in a sample of 108 untreated middle-aged subjects was related to impaired diastolic function. 14 Whereas Trika et al., 2004 , found out among 198 subjects that in elderly hypertensive patients without LV hypertrophy, a large PP at night may serve as an independent predictor of abnormal LV diastolic filling. 15 In our study, higher age, female gender, higher prevalence of diabetes, shorter stature, heavier weight, higher in-office SBP and PP, and higher NT-proANP were associated with LVDD during a long-term follow-up. In previous studies, the risk factors have been shown to be similar. Owan et al., 2006, showed that the patients with HFpEF were older, more often female and had higher body mass index compared with those with HFrEF. 6 Also a substantial proportion of these patients have been shown to have diabetes 33 and they tend to have higher levels of ANP (atrial natriuretic peptide). 34 Short stature is considered an independent risk factor of LVDD, 35 and Perkiömäki et al., 2016, discovered the association independently of gender. 32 So it is highly likely that shorter stature is an actual risk factor among both genders.
LVDD is often the consequence of hypertension. 6,36 Elevated BP increases LVM, 36, 37 which favor the development of LVDD. In our study, baseline in-office SBP and PP were associated with LVDD at follow-up indicating their predictive value in risk determination. The increased baseline NT-proANP concentrations provide evidence for compromised pump function of the heart even at this early stage. Although systolic ABPM at baseline did not predict the development of LVDD, a minor trend was discovered. Most importantly, APPM did in fact predict the development of LVDD at follow-up even after adjustment with relevant risk indicators. Increased PP may contribute to cardiac structural changes possibly through the pulsatile load on the heart, 38 and large arterial stiffness may increase the workload on the heart, leading to LV hypertrophy and cardiac dysfunction. 39 Arterial stiffness increase during aging and it is considered a risk marker for CV morbidity and mortality. 40 In our study, those who developed LVDD were older and had a higher inoffice PP at baseline, which is in alignment with the findings in previous studies. Unfortunately, any measurements indicating arterial stiffness in our study were not available.
During aging, SBP increases as a result of hardening of the arteries, which was also seen in our study population. A decrease in DBP was seen in our study population. Therefore, a significant increase in APP was observed in every subgroup, although the increase was observed to be the highest among the subjects who developed LVDD (E/E' ≥ 15). The subjects who developed LVDD seemed to have more severe hypertension compared to those whose E/E' <15.
As we did not have reliable echocardiographic parameters to evaluate LVDD in the early 1990's, therefore, we were unable to evaluate the actual development of LVDD. In the early 1990s, E/A-ratio was used as an indicator of LVDD. E/A-ratio is inversely associated with LVDD and it did not present any difference at baseline between the 3 E/E' subgroups in our study. It can be speculated that our study group did not present significant LVDD at baseline, All parameters are changes measured within 20 years. E/A integral = E integral = the area of the E wave, A wave describes the atrial booster in mitral flow in late diastole measured by pulsed Doppler, A integral = the area of the A wave, the ratio of E integral and A integral describes diastolic function. Abbreviations: DBP, diastolic blood pressure; IVS, intraventricular septum; LVIDD, left ventricular internal diameter in diastole; PP, pulse pressure; PVW, posterior ventricular wall; SBP, systolic blood pressure.
*Statistically significant P value.
even though E/A-ratio is not considered a reliable parameter indicating diastolic dysfunction.
In conclusion, APPM is an independent risk factor in the development of LVDD during later life-course. Further studies are needed to verify this finding.
